Advertisement

Ads Placeholder
Loading...

SCYNEXIS, Inc.

SCYX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.89
$-0.00(-0.05%)
U.S. Market opens in 0h 55m

SCYNEXIS, Inc. (SCYX) Stock Overview

Explore SCYNEXIS, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap39.7M
P/E Ratio-4.49
EPS (TTM)$-0.17
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$0.88
3 Months$0.90
1 Year Target$0.25

SCYX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SCYNEXIS, Inc. (SCYX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.05, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.49 and a market capitalization of 39.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.05%
5-Day Change
5.70%
1-Month Change
18.10%
3-Month Change
39.06%
6-Month Change
10.99%
Year-to-Date (YTD) Change
39.06%
1-Year Change
-1.41%
3-Year Change
-75.81%
5-Year Change
-89.38%
All-Time (Max) Change
-99.01%

Contact Information

https://www.scynexis.com
201 884 5485
1 Evertrust Plaza, Jersey City, NJ, 07302-6548

Company Facts

280 Employees
IPO DateMay 2, 2014
CountryUS
Actively Trading

Frequently Asked Questions